 Michaela Dolan
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 7 | 2021 | 768 | 0.660 |
Why?
| | HIV Envelope Protein gp120 | 5 | 2018 | 56 | 0.580 |
Why?
| | Structural Homology, Protein | 3 | 2012 | 23 | 0.500 |
Why?
| | Computer Simulation | 6 | 2012 | 880 | 0.480 |
Why?
| | Models, Molecular | 14 | 2018 | 1379 | 0.480 |
Why?
| | Protein Conformation | 7 | 2018 | 811 | 0.480 |
Why?
| | Proteins | 2 | 2012 | 912 | 0.460 |
Why?
| | Sequence Alignment | 4 | 2016 | 325 | 0.440 |
Why?
| | Algorithms | 2 | 2012 | 1474 | 0.430 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 16 | 0.340 |
Why?
| | CD4 Antigens | 3 | 2018 | 124 | 0.320 |
Why?
| | Genome, Viral | 3 | 2018 | 119 | 0.310 |
Why?
| | Software | 2 | 2012 | 537 | 0.310 |
Why?
| | Molecular Dynamics Simulation | 6 | 2017 | 201 | 0.300 |
Why?
| | HIV Antibodies | 4 | 2021 | 49 | 0.280 |
Why?
| | Antibodies, Neutralizing | 4 | 2021 | 221 | 0.240 |
Why?
| | Viral Proteins | 3 | 2017 | 281 | 0.240 |
Why?
| | Amyloid | 2 | 2014 | 80 | 0.230 |
Why?
| | Nucleic Acid Conformation | 5 | 2013 | 669 | 0.220 |
Why?
| | Binding Sites | 7 | 2017 | 1176 | 0.210 |
Why?
| | Amino Acid Sequence | 9 | 2021 | 1988 | 0.210 |
Why?
| | Protein Binding | 7 | 2018 | 1897 | 0.210 |
Why?
| | Ebolavirus | 2 | 2013 | 34 | 0.200 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2001 | 486 | 0.200 |
Why?
| | RNA, Bacterial | 3 | 2001 | 174 | 0.190 |
Why?
| | Escherichia coli | 3 | 2001 | 722 | 0.180 |
Why?
| | Protein Stability | 2 | 2018 | 157 | 0.180 |
Why?
| | Peptide Fragments | 2 | 2016 | 668 | 0.180 |
Why?
| | Tyrosine | 3 | 2016 | 216 | 0.160 |
Why?
| | Protein Multimerization | 2 | 2017 | 159 | 0.160 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2018 | 40 | 0.150 |
Why?
| | Metalloporphyrins | 1 | 1998 | 104 | 0.150 |
Why?
| | Leukemia Virus, Murine | 1 | 2017 | 16 | 0.150 |
Why?
| | Leukemia, Experimental | 1 | 2017 | 27 | 0.150 |
Why?
| | Host Specificity | 1 | 2017 | 22 | 0.150 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 43 | 0.150 |
Why?
| | Molecular Sequence Data | 8 | 2016 | 2791 | 0.150 |
Why?
| | Antigen Presentation | 2 | 2016 | 189 | 0.150 |
Why?
| | Retroviridae Infections | 1 | 2017 | 46 | 0.140 |
Why?
| | Protein Domains | 1 | 2018 | 207 | 0.140 |
Why?
| | RNA Viruses | 1 | 2017 | 28 | 0.140 |
Why?
| | Filoviridae Infections | 1 | 2016 | 4 | 0.140 |
Why?
| | Filoviridae | 1 | 2016 | 6 | 0.140 |
Why?
| | Norwalk virus | 1 | 2016 | 1 | 0.130 |
Why?
| | Molecular Mimicry | 1 | 2016 | 35 | 0.130 |
Why?
| | Genome, Human | 1 | 2018 | 352 | 0.130 |
Why?
| | Receptors, CCR5 | 1 | 2016 | 54 | 0.130 |
Why?
| | RNA, Viral | 2 | 2013 | 566 | 0.130 |
Why?
| | Single-Chain Antibodies | 1 | 2016 | 14 | 0.130 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 36 | 0.130 |
Why?
| | Immune Evasion | 2 | 2018 | 47 | 0.130 |
Why?
| | Adaptation, Biological | 1 | 2016 | 54 | 0.130 |
Why?
| | Viral Vaccines | 1 | 2017 | 89 | 0.130 |
Why?
| | Capsid Proteins | 1 | 2016 | 69 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 296 | 0.130 |
Why?
| | Immunoglobulins | 1 | 2016 | 143 | 0.130 |
Why?
| | Filaricides | 1 | 2015 | 1 | 0.120 |
Why?
| | Brugia malayi | 1 | 2015 | 3 | 0.120 |
Why?
| | PrPSc Proteins | 1 | 2014 | 5 | 0.120 |
Why?
| | Prion Diseases | 1 | 2014 | 10 | 0.120 |
Why?
| | Acyltransferases | 1 | 2014 | 46 | 0.120 |
Why?
| | Prions | 1 | 2014 | 33 | 0.120 |
Why?
| | Epitopes | 1 | 2016 | 436 | 0.110 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 112 | 0.110 |
Why?
| | RNA Editing | 1 | 2013 | 20 | 0.110 |
Why?
| | Virus Replication | 2 | 2017 | 395 | 0.110 |
Why?
| | Cytidine Deaminase | 2 | 2011 | 58 | 0.110 |
Why?
| | Base Sequence | 6 | 2017 | 2118 | 0.110 |
Why?
| | Codon | 2 | 2017 | 86 | 0.110 |
Why?
| | Receptors, Pattern Recognition | 1 | 2012 | 9 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2018 | 725 | 0.110 |
Why?
| | Lysine | 1 | 2014 | 242 | 0.100 |
Why?
| | Influenza, Human | 1 | 2018 | 546 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 522 | 0.100 |
Why?
| | Models, Chemical | 2 | 2008 | 250 | 0.100 |
Why?
| | H-2 Antigens | 1 | 2012 | 110 | 0.100 |
Why?
| | Sterol 14-Demethylase | 1 | 2011 | 1 | 0.100 |
Why?
| | Drug Resistance, Fungal | 1 | 2011 | 9 | 0.100 |
Why?
| | DNA | 1 | 1998 | 1351 | 0.100 |
Why?
| | Cryptococcus neoformans | 1 | 2011 | 18 | 0.100 |
Why?
| | Databases, Protein | 1 | 2012 | 59 | 0.100 |
Why?
| | Cryptococcosis | 1 | 2011 | 23 | 0.100 |
Why?
| | Animals | 14 | 2018 | 31839 | 0.100 |
Why?
| | Cytosine Deaminase | 1 | 2011 | 14 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 174 | 0.100 |
Why?
| | HIV Infections | 4 | 2021 | 2470 | 0.100 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 44 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 268 | 0.090 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 797 | 0.090 |
Why?
| | Fungal Proteins | 1 | 2011 | 119 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2011 | 3 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2011 | 5 | 0.090 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2011 | 26 | 0.090 |
Why?
| | Viral Matrix Proteins | 1 | 2011 | 24 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2013 | 2559 | 0.090 |
Why?
| | Ribosomes | 3 | 2001 | 148 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2011 | 129 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 848 | 0.090 |
Why?
| | Interleukin-13 | 1 | 2011 | 122 | 0.090 |
Why?
| | HEK293 Cells | 3 | 2018 | 593 | 0.090 |
Why?
| | Interferon-alpha | 1 | 2011 | 187 | 0.090 |
Why?
| | Bacterial Proteins | 2 | 2014 | 739 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2016 | 1022 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1233 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 796 | 0.080 |
Why?
| | RNA Interference | 1 | 2011 | 437 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 543 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2017 | 1153 | 0.080 |
Why?
| | Mice | 8 | 2017 | 14936 | 0.080 |
Why?
| | Crystallography | 1 | 2008 | 25 | 0.080 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 115 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 692 | 0.070 |
Why?
| | BRCA1 Protein | 1 | 2007 | 56 | 0.070 |
Why?
| | Neutralization Tests | 2 | 2018 | 63 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3549 | 0.070 |
Why?
| | DNA Repair | 1 | 2007 | 186 | 0.070 |
Why?
| | Cell Line | 3 | 2017 | 2640 | 0.060 |
Why?
| | Surface Plasmon Resonance | 2 | 2017 | 83 | 0.060 |
Why?
| | Mutagenesis | 2 | 2017 | 170 | 0.060 |
Why?
| | Humans | 18 | 2021 | 114937 | 0.060 |
Why?
| | Base Pairing | 2 | 2004 | 59 | 0.060 |
Why?
| | Water | 1 | 2008 | 399 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 612 | 0.060 |
Why?
| | Tombusviridae | 1 | 2004 | 1 | 0.060 |
Why?
| | Macrophages | 1 | 2011 | 1266 | 0.060 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 17 | 0.060 |
Why?
| | Vero Cells | 2 | 2017 | 63 | 0.060 |
Why?
| | Polysaccharides | 2 | 2014 | 78 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 2014 | 325 | 0.060 |
Why?
| | Mutation | 3 | 2021 | 3354 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1530 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 353 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2012 | 405 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1317 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 503 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 198 | 0.050 |
Why?
| | RNA, Transfer, Met | 1 | 2000 | 6 | 0.050 |
Why?
| | Peptide Initiation Factors | 1 | 2000 | 17 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2017 | 437 | 0.040 |
Why?
| | Pyrimidines | 2 | 2015 | 378 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 176 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 238 | 0.040 |
Why?
| | Spectinomycin | 1 | 1999 | 2 | 0.040 |
Why?
| | Tetracycline | 1 | 1999 | 11 | 0.040 |
Why?
| | Spectrophotometry, Atomic | 1 | 1998 | 13 | 0.040 |
Why?
| | Intercalating Agents | 1 | 1998 | 5 | 0.040 |
Why?
| | Neuraminidase | 1 | 2018 | 22 | 0.040 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 20 | 0.040 |
Why?
| | HIV Envelope Protein gp160 | 1 | 2018 | 7 | 0.040 |
Why?
| | HIV Antigens | 1 | 2018 | 17 | 0.040 |
Why?
| | Cations | 1 | 1998 | 79 | 0.040 |
Why?
| | Circular Dichroism | 1 | 1998 | 135 | 0.040 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 1998 | 86 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 40 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2018 | 41 | 0.040 |
Why?
| | Antibodies, Monoclonal | 2 | 2016 | 1270 | 0.040 |
Why?
| | Terminal Repeat Sequences | 1 | 2017 | 15 | 0.040 |
Why?
| | Sequence Homology | 1 | 2017 | 39 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 372 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2017 | 75 | 0.040 |
Why?
| | RNA Splicing | 1 | 2018 | 245 | 0.040 |
Why?
| | Bronchi | 1 | 2018 | 243 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 748 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 473 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2017 | 116 | 0.030 |
Why?
| | Calicivirus, Feline | 1 | 2016 | 2 | 0.030 |
Why?
| | Vaccines, Attenuated | 1 | 2017 | 112 | 0.030 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 125 | 0.030 |
Why?
| | Cryoelectron Microscopy | 1 | 2017 | 144 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2016 | 143 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 390 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 449 | 0.030 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2017 | 61 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2016 | 102 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2016 | 51 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 254 | 0.030 |
Why?
| | Cattle | 1 | 1998 | 924 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 402 | 0.030 |
Why?
| | Capsid | 1 | 2016 | 75 | 0.030 |
Why?
| | Virulence | 1 | 2016 | 228 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2015 | 63 | 0.030 |
Why?
| | Mesocricetus | 1 | 2014 | 30 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2015 | 75 | 0.030 |
Why?
| | Polyelectrolytes | 1 | 2014 | 13 | 0.030 |
Why?
| | Dasatinib | 1 | 2015 | 46 | 0.030 |
Why?
| | RNA | 1 | 2001 | 810 | 0.030 |
Why?
| | Cord Factors | 1 | 2014 | 1 | 0.030 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 2014 | 2 | 0.030 |
Why?
| | Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 2 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 2014 | 23 | 0.030 |
Why?
| | Galactans | 1 | 2014 | 4 | 0.030 |
Why?
| | Thiazoles | 1 | 2015 | 110 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 114 | 0.030 |
Why?
| | Cell Wall | 1 | 2014 | 52 | 0.030 |
Why?
| | Benzamides | 1 | 2015 | 169 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 60 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 191 | 0.030 |
Why?
| | Larva | 1 | 2015 | 194 | 0.030 |
Why?
| | Disulfides | 1 | 2014 | 90 | 0.030 |
Why?
| | Proteolysis | 1 | 2014 | 143 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2014 | 197 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 354 | 0.030 |
Why?
| | Kinetics | 1 | 2017 | 1555 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 239 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2018 | 958 | 0.030 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2012 | 21 | 0.030 |
Why?
| | Piperazines | 1 | 2015 | 313 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2012 | 45 | 0.030 |
Why?
| | 14-alpha Demethylase Inhibitors | 1 | 2011 | 1 | 0.030 |
Why?
| | Itraconazole | 1 | 2011 | 7 | 0.020 |
Why?
| | Fluconazole | 1 | 2011 | 16 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1523 | 0.020 |
Why?
| | Voriconazole | 1 | 2011 | 24 | 0.020 |
Why?
| | APOBEC Deaminases | 1 | 2011 | 5 | 0.020 |
Why?
| | Phenylalanine | 1 | 2011 | 57 | 0.020 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2011 | 23 | 0.020 |
Why?
| | Calmodulin | 1 | 2011 | 71 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1151 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1422 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 447 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 101 | 0.020 |
Why?
| | APOBEC-3G Deaminase | 1 | 2010 | 6 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2011 | 59 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 301 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 130 | 0.020 |
Why?
| | Animals, Wild | 1 | 2010 | 44 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2010 | 61 | 0.020 |
Why?
| | Ligands | 1 | 2012 | 565 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2010 | 152 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1087 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 668 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2011 | 132 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1477 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2011 | 295 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 139 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 617 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2010 | 243 | 0.020 |
Why?
| | Anti-Retroviral Agents | 1 | 2010 | 207 | 0.020 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2007 | 14 | 0.020 |
Why?
| | Porosity | 1 | 2008 | 89 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1644 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 138 | 0.020 |
Why?
| | NF-kappa B | 1 | 2011 | 637 | 0.020 |
Why?
| | Ultraviolet Rays | 2 | 2000 | 366 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1775 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2004 | 1317 | 0.020 |
Why?
| | Female | 3 | 2018 | 59581 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2004 | 200 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 80 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2324 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 4719 | 0.010 |
Why?
| | Prokaryotic Initiation Factor-3 | 1 | 2000 | 6 | 0.010 |
Why?
| | Alkalies | 1 | 2000 | 7 | 0.010 |
Why?
| | Anticodon | 1 | 2000 | 22 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 175 | 0.010 |
Why?
| | Ribosomal Proteins | 1 | 2000 | 70 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1133 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2102 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 319 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4525 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2000 | 344 | 0.010 |
Why?
| | Male | 1 | 2015 | 55663 | 0.010 |
Why?
|
|
Dolan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|